ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ) today announced U.S. Food and Drug Administration (FDA) and European CE Mark approvals of a 10-year battery longevity claim for the Eon® neurostimulator, a rechargeable device used to treat chronic pain. The announcement was made today at the 24th annual meeting of the American Academy of Pain Medicine in Orlando, Fla.
